Your browser doesn't support javascript.
loading
Identifying core MRI sequences for reliable automatic brain metastasis segmentation.
Buchner, Josef A; Peeken, Jan C; Etzel, Lucas; Ezhov, Ivan; Mayinger, Michael; Christ, Sebastian M; Brunner, Thomas B; Wittig, Andrea; Menze, Bjoern H; Zimmer, Claus; Meyer, Bernhard; Guckenberger, Matthias; Andratschke, Nicolaus; El Shafie, Rami A; Debus, Jürgen; Rogers, Susanne; Riesterer, Oliver; Schulze, Katrin; Feldmann, Horst J; Blanck, Oliver; Zamboglou, Constantinos; Ferentinos, Konstantinos; Bilger, Angelika; Grosu, Anca L; Wolff, Robert; Kirschke, Jan S; Eitz, Kerstin A; Combs, Stephanie E; Bernhardt, Denise; Rueckert, Daniel; Piraud, Marie; Wiestler, Benedikt; Kofler, Florian.
Afiliación
  • Buchner JA; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany. Electronic address: j.buchner@tum.de.
  • Peeken JC; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany; Institute of Radiation Medicine (IRM), Department of Radiation Sciences (DRS), Helmholtz C
  • Etzel L; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.
  • Ezhov I; Department of Informatics, Technical University of Munich, Munich, Germany; TranslaTUM - Central Institute for Translational Cancer Research, Technical University of Munich, Munich, Germany.
  • Mayinger M; Department of Radiation Oncology, University Hospital and University of Zurich, Zurich, Switzerland.
  • Christ SM; Department of Radiation Oncology, University Hospital and University of Zurich, Zurich, Switzerland.
  • Brunner TB; Department of Radiation Oncology, University Hospital Magdeburg, Magdeburg, Germany.
  • Wittig A; Department of Radiotherapy and Radiation Oncology, University Hospital Jena, Friedrich-Schiller University, Jena, Germany.
  • Menze BH; Department of Informatics, Technical University of Munich, Munich, Germany; Department of Quantitative Biomedicine, University Hospital and University of Zurich, Zurich, Switzerland.
  • Zimmer C; Department of Diagnostic and Interventional Neuroradiology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
  • Meyer B; Department of Neurosurgery, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
  • Guckenberger M; Department of Radiation Oncology, University Hospital and University of Zurich, Zurich, Switzerland.
  • Andratschke N; Department of Radiation Oncology, University Hospital and University of Zurich, Zurich, Switzerland.
  • El Shafie RA; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute for Radiation Oncology (HIRO), National Center for Radiation Oncology (NCRO), Heidelberg, Germany; Department of Radiation Oncology, University Medical Center Göttingen, Göttingen, Germany.
  • Debus J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute for Radiation Oncology (HIRO), National Center for Radiation Oncology (NCRO), Heidelberg, Germany.
  • Rogers S; Radiation Oncology Center KSA-KSB, Kantonsspital Aarau, Aarau, Switzerland.
  • Riesterer O; Radiation Oncology Center KSA-KSB, Kantonsspital Aarau, Aarau, Switzerland.
  • Schulze K; Department of Radiation Oncology, General Hospital Fulda, Fulda, Germany.
  • Feldmann HJ; Department of Radiation Oncology, General Hospital Fulda, Fulda, Germany.
  • Blanck O; Department of Radiation Oncology, University Medical Center Schleswig Holstein, Kiel, Germany.
  • Zamboglou C; Department of Radiation Oncology, University of Freiburg - Medical Center, Freiburg, Germany; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany; Department of Radiation Oncology, German Oncology Center, European University of Cyprus, Limassol, Cyprus.
  • Ferentinos K; Department of Radiation Oncology, German Oncology Center, European University of Cyprus, Limassol, Cyprus.
  • Bilger A; Department of Radiation Oncology, University of Freiburg - Medical Center, Freiburg, Germany; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany.
  • Grosu AL; Department of Radiation Oncology, University of Freiburg - Medical Center, Freiburg, Germany; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany.
  • Wolff R; Saphir Radiosurgery Center Frankfurt and Northern Germany, Guestrow, Germany; Department of Neurosurgery, University Hospital Frankfurt, Frankfurt, Germany.
  • Kirschke JS; Department of Diagnostic and Interventional Neuroradiology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
  • Eitz KA; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany; Institute of Radiation Medicine (IRM), Department of Radiation Sciences (DRS), Helmholtz C
  • Combs SE; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany; Institute of Radiation Medicine (IRM), Department of Radiation Sciences (DRS), Helmholtz C
  • Bernhardt D; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.
  • Rueckert D; Institute for Artificial Intelligence and Informatics in Medicine, Technical University of Munich, Munich, Germany.
  • Piraud M; Helmholtz AI, Helmholtz Zentrum Munich, Neuherberg, Germany.
  • Wiestler B; TranslaTUM - Central Institute for Translational Cancer Research, Technical University of Munich, Munich, Germany; Department of Diagnostic and Interventional Neuroradiology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
  • Kofler F; Helmholtz AI, Helmholtz Zentrum Munich, Neuherberg, Germany; Department of Informatics, Technical University of Munich, Munich, Germany; TranslaTUM - Central Institute for Translational Cancer Research, Technical University of Munich, Munich, Germany; Department of Diagnostic and Interventional Neur
Radiother Oncol ; 188: 109901, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37678623
ABSTRACT

BACKGROUND:

Many automatic approaches to brain tumor segmentation employ multiple magnetic resonance imaging (MRI) sequences. The goal of this project was to compare different combinations of input sequences to determine which MRI sequences are needed for effective automated brain metastasis (BM) segmentation.

METHODS:

We analyzed preoperative imaging (T1-weighted sequence ± contrast-enhancement (T1/T1-CE), T2-weighted sequence (T2), and T2 fluid-attenuated inversion recovery (T2-FLAIR) sequence) from 339 patients with BMs from seven centers. A baseline 3D U-Net with all four sequences and six U-Nets with plausible sequence combinations (T1-CE, T1, T2-FLAIR, T1-CE + T2-FLAIR, T1-CE + T1 + T2-FLAIR, T1-CE + T1) were trained on 239 patients from two centers and subsequently tested on an external cohort of 100 patients from five centers.

RESULTS:

The model based on T1-CE alone achieved the best segmentation performance for BM segmentation with a median Dice similarity coefficient (DSC) of 0.96. Models trained without T1-CE performed worse (T1-only DSC = 0.70 and T2-FLAIR-only DSC = 0.73). For edema segmentation, models that included both T1-CE and T2-FLAIR performed best (DSC = 0.93), while the remaining four models without simultaneous inclusion of these both sequences reached a median DSC of 0.81-0.89.

CONCLUSIONS:

A T1-CE-only protocol suffices for the segmentation of BMs. The combination of T1-CE and T2-FLAIR is important for edema segmentation. Missing either T1-CE or T2-FLAIR decreases performance. These findings may improve imaging routines by omitting unnecessary sequences, thus allowing for faster procedures in daily clinical practice while enabling optimal neural network-based target definitions.
Palabras clave

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Radiother Oncol Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Radiother Oncol Año: 2023 Tipo del documento: Article